Targeting the MAPK/ERK and PI3K/AKT Signaling Pathways Affects NRF2, Trx and GSH Antioxidant Systems in Leukemia CellsEwa Jasek-Gajda, Grzegorz Lis|Antioxidants|2020Cited by 72
Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cellsEwa Jasek-Gajda, Grzegorz Lis|APOPTOSIS|2019Cited by 23